Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years.

Cancer6.20
Volume: 123, Issue: 4, Pages: 592 - 599
Published: Feb 15, 2017
Abstract
Background null Two large-scale prostate cancer screening trials using prostate-specific antigen (PSA) have given conflicting results in terms of the efficacy of such screening. One of those trials, the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, previously reported outcomes with 13 years of follow-up. This study presents updated findings from the PLCO trial. null Methods null The PLCO trial randomized subjects from...
Paper Details
Title
Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years.
Published Date
Feb 15, 2017
Journal
Volume
123
Issue
4
Pages
592 - 599
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.